Answers are grounded in this paper and cite their sources.
Differences in morbidity rates between males and females have been reported for many cancer sites. Specifically, in the colon, cancers in females are more commonly detected in the right colon, are more often microsatellite instable (MSI-H) and differ in clinical behaviour ( Meza et al, 2010 ; Arnold et al, 2016 ). While differences in lifestyle such as smoking, alcohol consumption, occupational exposures can partly explain some of the gender difference, reproductive and hormonal factors are additional highly plausible explanatory factors. Exposure to female sex hormones was shown to be associated with cancer promotion in many leading tumour sites such as the breast, ovary, endometrium and thyroid ( Santen et al, 2010 ; Xhaard et al, 2014 ; Chlebowski et al, 2015 ). The use of postmenopausal hormone replacement therapy (HRT) has been shown to increase the risk of these cancers, but not the risk of colorectal, stomach or lung cancers ( Rennert et al, 2009 ; Camargo et al, 2012 ; Clague et al, 2014 ; Wang et al, 2016 ) where oestrogen exposure was associated with reduced, rather than increased, risk.
No takes yet. Share an insight, caveat, or question.
Gad Rennert (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: